Maxcyte (MXCT) Net Equity Issued and Repurchased (2021)
Maxcyte's (MXCT) quarterly Net Equity Issued and Repurchased came in at -$184.3 million in Q4 2021, down 200.0% quarter-over-quarter from $184.3 million in Q3 2021.
Powered by 
Analysis
Maxcyte (MXCT) Net Equity Issued and Repurchased (2021) Analysis & Trends
Maxcyte (MXCT) has reported Net Equity Issued and Repurchased for 1 consecutive years, with -$184.3 million the latest figure, recorded in Q4 2021.
- On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to -$184.3 million in Q4 2021; TTM through Dec 2021 was $51.8 million, a N/A change from a year earlier, with the FY2021 full-year figure at $51.8 million, up 81.36% from the prior year.
- Net Equity Issued and Repurchased was -$184.3 million for Q4 2021 at Maxcyte, down from $184.3 million in the prior quarter.
- Over five years, Net Equity Issued and Repurchased peaked at $184.3 million in Q3 2021 and troughed at -$184.3 million in Q4 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 225.48 Bn | 221.41 Bn | 8.34 Bn | - |
| 2 | Danaher | 144.42 Bn | 140.08 Bn | 3.61 Bn | - |
| 3 | Agilent Technologies | 40.86 Bn | 39.11 Bn | 1.04 Bn | - |
| 4 | Illumina | 30.97 Bn | 29.80 Bn | 770.00 Mn | - |
| 5 | Revvity | 13.85 Bn | 12.83 Bn | 416.87 Mn | - |
| 6 | Bio-Techne | 11.27 Bn | 11.01 Bn | 211.39 Mn | - |
| 7 | Bio-Rad Laboratories | 10.11 Bn | 8.49 Bn | 345.80 Mn | 4.20 Mn |
| 8 | Repligen | 9.33 Bn | 8.31 Bn | 110.04 Mn | - |
| 9 | 10x Genomics | 8.77 Bn | 8.21 Bn | 112.50 Mn | - |
| 10 | Maxcyte | 131.93 Mn | 131.93 Mn | 5.60 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2021 | -184.27 Mn |
| Sep 30, 2021 | 184.27 Mn |
| Mar 31, 2021 | 51.81 Mn |